P/B 와 P/E 의 괴리 — 세 가지 정의로 본 한국·일본·미국The gap between P/B and P/E — Korea, Japan and the US through three definitionsPBRとPERの乖離 — 三つの定義で見た韓国・日本・米国
P/B 는 P/E 에 ROE 를 곱한 값이다. 그래서 P/B 는 비싼데 P/E 는 싸 보이는 회사는 지금 이익이 평소보다 많은 회사다. 이 괴리를 무엇에 견주느냐에 따라 세 가지로 정의했다 — ① 그 회사의 평소, ② 같은 해 같은 시장의 비슷한 회사, ③ 지금 값이 내놓는 수익률. 세 정의를 한국 225사 · 일본 418사 · 미국 36사에 똑같이 적용하고, 서로 얼마나 겹치는지와 그 뒤 P/B 가 어떻게 움직였는지를 견준다.P/B is P/E multiplied by ROE. So a company whose P/B is expensive while its P/E looks cheap is one whose earnings are currently above their usual level. This gap is defined in three ways, depending on what it is compared with — ① the company's own usual level, ② similar companies in the same market and year, ③ the return implied by today's price. The three definitions are applied in the same way to 225 Korean, 418 Japanese and 36 US companies, comparing how much they overlap and how P/B moved afterwards.PBRはPERにROEを掛けた値である。したがって、PBRは割高なのにPERは割安に見える企業は、いま利益が平常より多い企業である。この乖離を何と比べるかによって三通りに定義した — ① その企業の平常値、② 同じ年・同じ市場の似た企業、③ 現在の株価が示す収益率。三つの定義を韓国225社・日本418社・米国36社に同じように適用し、互いにどれだけ重なるか、その後PBRがどう動いたかを比べる。
한국 2026Q3 · 일본 FY2025 · 미국 회사별 최근 회계연도Korea 2026Q3 · Japan FY2025 · US latest fiscal year by company韓国 2026Q3 · 日本 FY2025 · 米国 各社の直近会計年度정기보고서 재무 + 분기말·기말 시가총액Periodic-report financials + quarter-end and year-end market capitalisation定期報告書の財務 + 四半期末・期末の時価総額세 정의 × 세 시장Three definitions × three markets三つの定義 × 三市場
먼저 보는 세 줄 · 2026-09-30Three lines first · 2026-09-30まず見る三行 · 2026-09-30
P/B = P/E × ROE. 시가총액 가중으로 본 P/B 의 평소 대비 초과분은 한국 +47(배수 -27 · 이익 +75) · 일본 +17(배수 +12 · 이익 +4) · 미국 -3(배수 -26 · 이익 +23). 내재 수익률 − 국채 10년(중앙 회사)은 한국 +1.4%p · 일본 +5.0%p · 미국 +0.3%p. 지난 표본에서 뒤따른 P/B 변화와 가장 맞았던 정의: 한국 ① 자기 역사(-0.12) · 일본 ③ 내재 수익률(-0.20) · 미국 ③ 내재 수익률(-0.15).P/B = P/E × ROE. On a market-cap-weighted basis, P/B in excess of its usual level: Korea +47 (multiple -27 · earnings +75) · Japan +17 (multiple +12 · earnings +4) · US -3 (multiple -26 · earnings +23). Implied return − 10-year government bond yield (median company): Korea +1.4pp · Japan +5.0pp · US +0.3pp. The definition that best matched the subsequent change in P/B in the past sample: Korea ① own history (-0.12) · Japan ③ implied return (-0.20) · US ③ implied return (-0.15).PBR = PER × ROE。時価総額加重で見たPBRの平常値からの超過分は韓国+47(倍率-27 · 利益+75) · 日本+17(倍率+12 · 利益+4) · 米国-3(倍率-26 · 利益+23)。インプライド期待収益率 − 10年国債(中央値の企業)は韓国+1.4%pt · 日本+5.0%pt · 米国+0.3%pt。過去の標本でその後のPBR変化と最も合っていた定義:韓国① 自社の過去(-0.12) · 日本③ インプライド期待収益率(-0.20) · 米国③ インプライド期待収益率(-0.15)。
한국 P/B 평소 대비(시총 가중)Korea P/B vs usual (cap-weighted)韓国のPBR平常値比(時価総額加重)
중앙 회사 4.4% · 가중 2.5%median company 4.4% · weighted 2.5%中央値の企業4.4% · 加重2.5%
① 회사마다 P/B·P/E 의 로그값에서 직전까지의 자기 평균을 뺀다(이익이 난 기간만). ② 기간마다 회사들의 P/B 를 ROE·FCF/자본·자기자본비율로 설명하고 남는 부분을 본다. ③ ROE 가 최근 평균에서 시장 중앙으로 서서히 수렴하고 이익을 모두 환원한다고 놓고 지금 P/B 가 내놓는 수익률을 푼다. 숫자는 정기보고서와 기말 시가총액에서 계산했다.① For each company, its own prior average is subtracted from the logs of P/B and P/E (profitable periods only). ② In each period, the companies' P/B is explained by ROE, FCF-to-equity and equity ratio, and the unexplained part is examined. ③ Assuming ROE converges gradually from its recent average to the market median and all earnings are paid out, the return implied by today's P/B is solved for. Figures are calculated from periodic reports and year-end market capitalisation.① 企業ごとにPBR・PERの対数値から直前までの自社平均を引く(利益が出た期間のみ)。② 期間ごとに各社のPBRをROE・FCF/自己資本・自己資本比率で説明し、残る部分を見る。③ ROEが直近平均から市場の中央値へ徐々に収束し、利益をすべて還元すると置いて、現在のPBRが示す収益率を解く。数値は定期報告書と期末の時価総額から計算した。
00
한 줄In one line一行で
P/B = P/E × ROE. 시가총액 가중으로 본 P/B 의 평소 대비 초과분은 한국 +47(배수 -27 · 이익 +75) · 일본 +17(배수 +12 · 이익 +4) · 미국 -3(배수 -26 · 이익 +23). 내재 수익률 − 국채 10년(중앙 회사)은 한국 +1.4%p · 일본 +5.0%p · 미국 +0.3%p. 지난 표본에서 뒤따른 P/B 변화와 가장 맞았던 정의: 한국 ① 자기 역사(-0.12) · 일본 ③ 내재 수익률(-0.20) · 미국 ③ 내재 수익률(-0.15).
P/B = P/E × ROE. On a market-cap-weighted basis, P/B in excess of its usual level: Korea +47 (multiple -27 · earnings +75) · Japan +17 (multiple +12 · earnings +4) · US -3 (multiple -26 · earnings +23). Implied return − 10-year government bond yield (median company): Korea +1.4pp · Japan +5.0pp · US +0.3pp. The definition that best matched the subsequent change in P/B in the past sample: Korea ① own history (-0.12) · Japan ③ implied return (-0.20) · US ③ implied return (-0.15).
정의 ① 자기 역사 — P/B 가 평소보다 높은 만큼 = P/E 몫 + ROE 몫Definition ① own history — how far P/B is above its usual level = P/E part + ROE part定義① 自社の過去 — PBRが平常値を上回る分 = PER要因 + ROE要因
정의 ①Definition ①定義①Latest P/B against each company's own prior average, split into a P/E part and an ROE part
P/B = P/E × ROE 이므로, P/B 가 자기 평소보다 높은 정도는 P/E 가 높은 정도(배수 몫)와 ROE 가 높은 정도(이익 몫)의 합이다. 두 배수의 괴리는 이익 몫이다. 한국 중앙 회사 +12.7 = 배수 +8.5 + 이익 +7.6, 시가총액 가중 +47.0 = 배수 -27.5 + 이익 +74.5. 일본 중앙 회사 -0.7 = 배수 -12.1 + 이익 +15.2, 시가총액 가중 +16.6 = 배수 +12.4 + 이익 +4.2. 미국 중앙 회사 +16.8 = 배수 +6.7 + 이익 -2.5, 시가총액 가중 -3.2 = 배수 -26.0 + 이익 +22.9.
Since P/B = P/E × ROE, how far P/B is above its own usual level is the sum of how far P/E is above its usual level (the multiple part) and how far ROE is above its usual level (the earnings part). The gap between the two multiples is the earnings part. Korea median company +12.7 = multiple +8.5 + earnings +7.6, market-cap weighted +47.0 = multiple -27.5 + earnings +74.5. Japan median company -0.7 = multiple -12.1 + earnings +15.2, market-cap weighted +16.6 = multiple +12.4 + earnings +4.2. US median company +16.8 = multiple +6.7 + earnings -2.5, market-cap weighted -3.2 = multiple -26.0 + earnings +22.9.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 이익이 난 기간만 쓴다(적자 기간은 P/E 가 없다) · '평소'는 그 회사의 직전까지 평균이라 자료가 시작된 뒤의 값이다 · 시가총액 가중값은 큰 회사 몇 곳이 좌우한다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Only profitable periods are used (loss periods have no P/E) · the 'usual' level is the company's own average up to the previous period, so it covers only the time since its data begin · cap-weighted values are driven by a few large companies · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
정의 ①Definition ①定義①Where companies sit: P/B and P/E against their own prior averages
P/B 와 P/E 가 둘 다 평소보다 높은 회사(배수가 늘어난 쪽): 한국 41% · 일본 30% · 미국 46%. P/B 만 높고 P/E 는 낮은 회사(이익이 평소보다 많아 P/E 가 낮아 보이는 쪽): 한국 23% · 일본 19% · 미국 18%.
Companies with both P/B and P/E above their usual levels (the multiple has expanded): Korea 41% · Japan 30% · US 46%. Companies with P/B above but P/E below (earnings above usual, so P/E looks low): Korea 23% · Japan 19% · US 18%.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 이익이 난 기간만 쓴다(적자 기간은 P/E 가 없다) · '평소'는 그 회사의 직전까지 평균이라 자료가 시작된 뒤의 값이다 · 시가총액 가중값은 큰 회사 몇 곳이 좌우한다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Only profitable periods are used (loss periods have no P/E) · the 'usual' level is the company's own average up to the previous period, so it covers only the time since its data begin · cap-weighted values are driven by a few large companies · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
한국Korea韓国Korea: median P/B gap to own history and its two parts, by quarter
⚠ 규율: 한국은 분기말 시가총액과 직전 4분기 이익이 함께 있는 기간이 짧아 최근 5개 분기만 잴 수 있다.
⚠ Discipline: In Korea the period with both quarter-end market capitalisation and trailing four-quarter earnings is short, so only the latest 5 quarters can be measured.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 이익이 난 기간만 쓴다(적자 기간은 P/E 가 없다) · '평소'는 그 회사의 직전까지 평균이라 자료가 시작된 뒤의 값이다 · 시가총액 가중값은 큰 회사 몇 곳이 좌우한다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Only profitable periods are used (loss periods have no P/E) · the 'usual' level is the company's own average up to the previous period, so it covers only the time since its data begin · cap-weighted values are driven by a few large companies · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
일본Japan日本Japan: median P/B gap to own history and its two parts, by fiscal year
Limitations: 이익이 난 기간만 쓴다(적자 기간은 P/E 가 없다) · '평소'는 그 회사의 직전까지 평균이라 자료가 시작된 뒤의 값이다 · 시가총액 가중값은 큰 회사 몇 곳이 좌우한다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Limitations: Only profitable periods are used (loss periods have no P/E) · the 'usual' level is the company's own average up to the previous period, so it covers only the time since its data begin · cap-weighted values are driven by a few large companies · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
미국US米国US: median P/B gap to own history and its two parts, by fiscal year
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 이익이 난 기간만 쓴다(적자 기간은 P/E 가 없다) · '평소'는 그 회사의 직전까지 평균이라 자료가 시작된 뒤의 값이다 · 시가총액 가중값은 큰 회사 몇 곳이 좌우한다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Only profitable periods are used (loss periods have no P/E) · the 'usual' level is the company's own average up to the previous period, so it covers only the time since its data begin · cap-weighted values are driven by a few large companies · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: U.S. Securities and Exchange Commission (EDGAR).
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
02
정의 ② 같은 해 동료 — ROE·FCF·자기자본비율이 같은 회사가 받는 P/BDefinition ② same-year peers — the P/B paid for a company with the same ROE, FCF and equity ratio定義② 同年の比較企業 — ROE・FCF・自己資本比率が同じ企業が受けるPBR
정의 ②Definition ②定義②P/B paid for the same reference company in each market, by year
같은 해 같은 시장의 회사들로 'ROE·FCF/자본·자기자본비율이 이만하면 P/B 는 이만큼'을 추정한 뒤, 세 시장에 똑같은 기준 회사(ROE 7.6% · FCF/자본 5.5% · 자기자본비율 52%)를 넣었다. 가장 최근: 한국 1.39배 · 일본 0.92배 · 미국 2.88배.
From the companies in the same market and year, the P/B that goes with a given ROE, FCF-to-equity and equity ratio was estimated, and the same reference company (ROE 7.6% · FCF-to-equity 5.5% · equity ratio 52%) was put into all three markets. Latest: Korea 1.39x · Japan 0.92x · US 2.88x.
⚠ 규율: 한국은 그 해 4분기(올해는 2026Q3), 일본·미국은 회계연도. 미국 값은 비계열 보유 시가총액 기준이라 실제 시가총액 기준보다 낮다.
⚠ Discipline: Korea uses Q4 of each year (for this year, 2026Q3); Japan and the US use fiscal years. US values are based on the market value held by non-affiliates, so they are lower than on a full market-capitalisation basis.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 회사별 잔차는 같은 기간 같은 시장 안의 상대값이라 평균이 0 이다 — 시장 전체의 수준은 '같은 회사에 매기는 P/B' 로만 본다 · 금융업은 현금흐름·자기자본비율 항을 쓰지 않았다 · 미국은 회사 수가 적어 여러 해를 모아 추정했다 · 일본의 FCF 는 영업현금흐름 + 투자현금흐름(유가증권 매매·인수 포함)이다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Company residuals are relative values within the same market and period, so they average zero — the level of the market as a whole is seen only through 'the P/B given to the same company' · for financials, the cash-flow and equity-ratio terms are not used · the US is estimated with several years pooled because it has few companies · Japan's FCF is operating cash flow + investing cash flow (including securities trading and acquisitions) · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
정의 ②Definition ②定義②How much of the P/B differences among companies the fundamentals explain
시장
ROE 1%p ↔ P/B
FCF/자본 1%p ↔ P/B
자기자본비율 10%p ↔ P/B
한국
+4.2%
-2.1%
+4.4%
일본
+7.5%
-0.5%
+1.7%
미국
+0.9%
+0.4%
-6.3%
다른 두 지표가 같을 때 그 지표가 높은 회사의 P/B 가 얼마나 높은가(가장 최근 기간).
Market
ROE 1pp ↔ P/B
FCF-to-equity 1pp ↔ P/B
Equity ratio 10pp ↔ P/B
Korea
+4.2%
-2.1%
+4.4%
Japan
+7.5%
-0.5%
+1.7%
US
+0.9%
+0.4%
-6.3%
How much higher P/B is for a company where that measure is higher, with the other two measures equal (latest period).
市場
ROE 1%pt ↔ PBR
FCF/自己資本 1%pt ↔ PBR
自己資本比率 10%pt ↔ PBR
韓国
+4.2%
-2.1%
+4.4%
日本
+7.5%
-0.5%
+1.7%
米国
+0.9%
+0.4%
-6.3%
他の二指標が同じとき、その指標が高い企業のPBRがどれだけ高いか(直近の期間)。
회사 간 P/B 차이 가운데 세 지표가 설명하는 몫: 한국 16%(ROE 만 8%) · 일본 39%(ROE 만 38%) · 미국 38%(ROE 만 35%). 이 정의는 설명력이 높은 시장일수록 믿을 만하다.
Share of the P/B differences among companies explained by the three measures: Korea 16% (ROE alone 8%) · Japan 39% (ROE alone 38%) · US 38% (ROE alone 35%). This definition is more reliable in markets where the explanatory power is higher.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 회사별 잔차는 같은 기간 같은 시장 안의 상대값이라 평균이 0 이다 — 시장 전체의 수준은 '같은 회사에 매기는 P/B' 로만 본다 · 금융업은 현금흐름·자기자본비율 항을 쓰지 않았다 · 미국은 회사 수가 적어 여러 해를 모아 추정했다 · 일본의 FCF 는 영업현금흐름 + 투자현금흐름(유가증권 매매·인수 포함)이다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Company residuals are relative values within the same market and period, so they average zero — the level of the market as a whole is seen only through 'the P/B given to the same company' · for financials, the cash-flow and equity-ratio terms are not used · the US is estimated with several years pooled because it has few companies · Japan's FCF is operating cash flow + investing cash flow (including securities trading and acquisitions) · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
정의 ②Definition ②定義②Spread of P/B among companies with the same fundamentals
세 지표가 같은 회사끼리도 P/B 는 갈린다. 가운데 절반 회사의 폭: 한국 144 · 일본 56 · 미국 86(로그 차이 × 100). 폭이 넓을수록 지금의 이익·현금흐름·재무구조로 설명되지 않는 값이 많이 매겨져 있다.
Even among companies with the same three measures, P/B differs. Range of the middle half of companies: Korea 144 · Japan 56 · US 86 (log difference × 100). The wider the range, the more value is priced in that today's earnings, cash flow and balance sheet do not explain.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 회사별 잔차는 같은 기간 같은 시장 안의 상대값이라 평균이 0 이다 — 시장 전체의 수준은 '같은 회사에 매기는 P/B' 로만 본다 · 금융업은 현금흐름·자기자본비율 항을 쓰지 않았다 · 미국은 회사 수가 적어 여러 해를 모아 추정했다 · 일본의 FCF 는 영업현금흐름 + 투자현금흐름(유가증권 매매·인수 포함)이다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: Company residuals are relative values within the same market and period, so they average zero — the level of the market as a whole is seen only through 'the P/B given to the same company' · for financials, the cash-flow and equity-ratio terms are not used · the US is estimated with several years pooled because it has few companies · Japan's FCF is operating cash flow + investing cash flow (including securities trading and acquisitions) · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
03
정의 ③ 역산 — 지금 P/B 가 내놓는 수익률Definition ③ reverse-engineered — the return implied by today's P/B定義③ 逆算 — 現在のPBRが示す収益率
정의 ③Definition ③定義③Return implied by today's P/B if ROE fades to the market median, by year
회사의 ROE 가 최근 평균에서 그 시장의 중앙값으로 서서히 수렴한다고 놓고, 지금 P/B 로 사면 얻는 수익률을 거꾸로 풀었다. 낮을수록 비싸다. 가장 최근 중앙 회사: 한국 5.8% · 일본 7.4% · 미국 4.4%. 시가총액 가중: 한국 3.9% · 일본 5.9% · 미국 2.5%.
Assuming each company's ROE converges gradually from its recent average to its market's median, the return from buying at today's P/B is solved backwards. The lower it is, the more expensive. Latest, median company: Korea 5.8% · Japan 7.4% · US 4.4%. Market-cap weighted: Korea 3.9% · Japan 5.9% · US 2.5%.
⚠ 규율: 수렴 속도를 절반으로 바꿔도 회사 순위는 거의 같다(순위상관 한국 0.99 · 일본 0.99 · 미국 0.99).
⚠ Discipline: Even with the convergence speed halved, the ranking of companies is almost the same (rank correlation: Korea 0.99 · Japan 0.99 · US 0.99).
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
정의 ③Definition ③定義③Implied return minus the 10-year government bond yield, by year
내재 수익률에서 그 나라 국채 10년 금리를 뺀 값(중앙 회사): 한국 +1.4%p · 일본 +5.0%p · 미국 +0.3%p.
Implied return minus the country's 10-year government bond yield (median company): Korea +1.4pp · Japan +5.0pp · US +0.3pp.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
정의 ③Definition ③定義③Latest implied return: median company, market-cap weighted, and the 10-year government yield
시가총액 가중 내재 수익률과 국채 10년: 한국 3.9% vs 4.41% · 일본 5.9% vs 2.37% · 미국 2.5% vs 4.24%. 한국·미국은 가중값이 국채 10년보다 낮다 — 큰 회사들의 주가가 '높은 ROE 가 이 가정보다 오래 가거나 장부가 더 빨리 늘어난다'를 값에 넣고 있다는 뜻이다.
Market-cap-weighted implied return and the 10-year government bond yield: Korea 3.9% vs 4.41% · Japan 5.9% vs 2.37% · US 2.5% vs 4.24%. Korea and US: the weighted value is below the 10-year yield — the share prices of the large companies are pricing in 'high ROE lasting longer than this assumption, or book value growing faster'.
時価総額加重のインプライド期待収益率と10年国債利回り:韓国3.9% vs 4.41% · 日本5.9% vs 2.37% · 米国2.5% vs 4.24%。韓国・米国は加重値が10年国債利回りより低い — 大企業の株価が「高いROEがこの仮定より長く続くか、簿価がより速く増える」ことを織り込んでいるという意味である。
⚠ 규율: 이 계산은 재투자로 늘어나는 장부를 넣지 않았다 — ROE 가 높은 대형주일수록 낮게 나오는 쪽으로 치우친다.
⚠ Discipline: This calculation leaves out book value that grows through reinvestment — it is biased downwards, the more so for large companies with high ROE.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
04
세 정의를 서로 견준다 — 겹치는 정도와 그 뒤의 P/BComparing the three definitions — how much they overlap, and P/B afterwards三つの定義を比べる — 重なり具合とその後のPBR
비교Comparison比較Do the three definitions rank companies the same way?
②와 ③은 순위가 거의 같다(한국 0.96 · 일본 0.84 · 미국 0.90) — 둘 다 'ROE 에 견준 P/B'를 재기 때문이다. ①은 다른 것을 잰다(①~② 한국 0.43 · 일본 0.12 · 미국 -0.24). 실제로는 자기 역사 대비와 이익·장부 대비 두 개의 눈금이 있는 셈이고, ③은 ②에 절대 수준(수익률)을 더한다.
② and ③ rank companies almost the same way (Korea 0.96 · Japan 0.84 · US 0.90) — both measure 'P/B against ROE'. ① measures something else (①~② Korea 0.43 · Japan 0.12 · US -0.24). In practice there are two yardsticks, against own history and against earnings and book value, and ③ adds an absolute level (a return) to ②.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 지난 표본에서 본 관계이고 통계적 입증이 아니다 · 한국은 1년 간격이 서로 겹치는 분기라 독립된 해는 2개 안팎, 미국은 한 해에 회사 십여 곳이다 · 뒤따른 변화는 같은 기간 표본 중앙 대비 P/B 변화이고 주가 수익률이 아니다 · 정의 ①은 '평소'를 만들 기간이 필요해 검증 기간이 더 짧다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is a relationship seen in the past sample, not statistical proof · for Korea the one-year windows are overlapping quarters, so there are only about two independent years, and the US has around a dozen companies a year · the subsequent change is the change in P/B against the sample median over the same period, not the share-price return · definition ① needs a period to build the 'usual' level, so its test period is shorter · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
비교Comparison比較How often the three definitions agree on a company
세 정의 모두에서 상위 3분의 1(비싼 쪽)인 회사: 한국 26사/139사 · 일본 34사/338사 · 미국 1사/20사. 세 정의 모두 하위 3분의 1: 한국 20사 · 일본 34사 · 미국 2사. 한 정의에선 비싸고 다른 정의에선 싼 회사: 한국 14사 · 일본 88사 · 미국 7사.
Companies in the top third (expensive side) on all three definitions: Korea 26 of 139 · Japan 34 of 338 · US 1 of 20. Bottom third on all three: Korea 20 · Japan 34 · US 2. Expensive on one definition and cheap on another: Korea 14 · Japan 88 · US 7.
⚠ 규율: 세 정의가 서로 무관하다면 모두 상위에 드는 회사는 한국 약 5사 · 일본 약 12사 · 미국 약 1사이다.
⚠ Discipline: If the three definitions were unrelated, the companies in the top third on all three would number: Korea about 5 · Japan about 12 · US about 1.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 지난 표본에서 본 관계이고 통계적 입증이 아니다 · 한국은 1년 간격이 서로 겹치는 분기라 독립된 해는 2개 안팎, 미국은 한 해에 회사 십여 곳이다 · 뒤따른 변화는 같은 기간 표본 중앙 대비 P/B 변화이고 주가 수익률이 아니다 · 정의 ①은 '평소'를 만들 기간이 필요해 검증 기간이 더 짧다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is a relationship seen in the past sample, not statistical proof · for Korea the one-year windows are overlapping quarters, so there are only about two independent years, and the US has around a dozen companies a year · the subsequent change is the change in P/B against the sample median over the same period, not the share-price return · definition ① needs a period to build the 'usual' level, so its test period is shorter · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
검증Test検証Which definition was followed by a lower P/B a year later?
시장
정의
순위상관(P/B)
기간 수
음수인 기간
순위상관(시가총액)
상위 − 하위 3분위 P/B 변화
한국
① 자기 역사
-0.12
1
100%
-0.06
-8.1
한국
② 동료
-0.04
8
75%
0.01
-2.0
한국
③ 내재 수익률
-0.11
8
100%
-0.07
-7.3
한국
셋 평균
-0.07
1
100%
0.00
+2.7
일본
① 자기 역사
-0.07
5
80%
-0.05
-5.1
일본
② 동료
-0.16
9
89%
-0.13
-8.2
일본
③ 내재 수익률
-0.20
9
100%
-0.12
-8.9
일본
셋 평균
-0.24
5
100%
-0.19
-10.8
미국
① 자기 역사
-0.01
5
60%
-0.12
+0.2
미국
② 동료
-0.10
10
70%
0.10
-7.6
미국
③ 내재 수익률
-0.15
10
90%
0.06
-9.1
미국
셋 평균
-0.31
5
100%
-0.03
-22.3
일본 · 3년 뒤
① 자기 역사
-0.22
3
100%
-0.15
-15.2
일본 · 3년 뒤
② 동료
-0.23
7
71%
-0.19
-18.6
일본 · 3년 뒤
③ 내재 수익률
-0.29
7
86%
-0.17
-23.2
일본 · 3년 뒤
셋 평균
-0.47
3
100%
-0.38
-39.2
'순위상관(시가총액)'은 P/B 대신 시가총액 변화로 본 값 — 장부가 늘어서 P/B 가 내려간 것인지, 값이 내려간 것인지를 가른다. 마지막 열은 로그 차이 × 100.
Market
Definition
Rank correlation (P/B)
Periods
Negative periods
Rank correlation (market cap)
Top − bottom tercile P/B change
Korea
① own history
-0.12
1
100%
-0.06
-8.1
Korea
② peers
-0.04
8
75%
0.01
-2.0
Korea
③ implied return
-0.11
8
100%
-0.07
-7.3
Korea
average of three
-0.07
1
100%
0.00
+2.7
Japan
① own history
-0.07
5
80%
-0.05
-5.1
Japan
② peers
-0.16
9
89%
-0.13
-8.2
Japan
③ implied return
-0.20
9
100%
-0.12
-8.9
Japan
average of three
-0.24
5
100%
-0.19
-10.8
US
① own history
-0.01
5
60%
-0.12
+0.2
US
② peers
-0.10
10
70%
0.10
-7.6
US
③ implied return
-0.15
10
90%
0.06
-9.1
US
average of three
-0.31
5
100%
-0.03
-22.3
Japan · 3 years later
① own history
-0.22
3
100%
-0.15
-15.2
Japan · 3 years later
② peers
-0.23
7
71%
-0.19
-18.6
Japan · 3 years later
③ implied return
-0.29
7
86%
-0.17
-23.2
Japan · 3 years later
average of three
-0.47
3
100%
-0.38
-39.2
'Rank correlation (market cap)' uses the change in market capitalisation instead of P/B — it separates P/B falling because book value grew from P/B falling because the price fell. The last column is log difference × 100.
각 정의로 '비싼' 회사일수록 그 뒤 1년 동안 P/B 가 (같은 기간 다른 회사들보다) 내려갔는지를 본 순위상관이다. 음수가 클수록 그 정의가 뒤따른 P/B 변화와 맞았다. 한국: ① -0.12(1개 기간 중 음수 100%) · ② -0.04(8개 기간 중 음수 75%) · ③ -0.11(8개 기간 중 음수 100%) · 셋 평균 -0.07(1개 기간 중 음수 100%). 일본: ① -0.07(5개 기간 중 음수 80%) · ② -0.16(9개 기간 중 음수 89%) · ③ -0.20(9개 기간 중 음수 100%) · 셋 평균 -0.24(5개 기간 중 음수 100%). 미국: ① -0.01(5개 기간 중 음수 60%) · ② -0.10(10개 기간 중 음수 70%) · ③ -0.15(10개 기간 중 음수 90%) · 셋 평균 -0.31(5개 기간 중 음수 100%).
Rank correlation showing whether companies that were 'expensive' on each definition saw their P/B fall over the following year (relative to other companies in the same period). The more negative it is, the better that definition matched the subsequent change in P/B. Korea: ① -0.12 (negative in 100% of 1 periods) · ② -0.04 (negative in 75% of 8 periods) · ③ -0.11 (negative in 100% of 8 periods) · average of three -0.07 (negative in 100% of 1 periods). Japan: ① -0.07 (negative in 80% of 5 periods) · ② -0.16 (negative in 89% of 9 periods) · ③ -0.20 (negative in 100% of 9 periods) · average of three -0.24 (negative in 100% of 5 periods). US: ① -0.01 (negative in 60% of 5 periods) · ② -0.10 (negative in 70% of 10 periods) · ③ -0.15 (negative in 90% of 10 periods) · average of three -0.31 (negative in 100% of 5 periods).
各定義で「割高」な企業ほど、その後1年間にPBRが(同じ期間の他社より)下がったかを見た順位相関である。負の値が大きいほど、その定義はその後のPBR変化と合っていた。韓国:① -0.12(1期間中マイナス100%) · ② -0.04(8期間中マイナス75%) · ③ -0.11(8期間中マイナス100%) · 三つの平均 -0.07(1期間中マイナス100%)。日本:① -0.07(5期間中マイナス80%) · ② -0.16(9期間中マイナス89%) · ③ -0.20(9期間中マイナス100%) · 三つの平均 -0.24(5期間中マイナス100%)。米国:① -0.01(5期間中マイナス60%) · ② -0.10(10期間中マイナス70%) · ③ -0.15(10期間中マイナス90%) · 三つの平均 -0.31(5期間中マイナス100%)。
⚠ 규율: 한국의 정의 ①과 '셋 평균'은 견줄 기간이 아직 없다. 막대가 없는 칸이 그 자리다.
⚠ Discipline: Korea's definition ① and 'average of three' have no periods to compare yet. The slots without bars are those.
⚠ 規律:韓国の定義①と「三つの平均」は、まだ比べる期間がない。棒のない枠がそれにあたる。
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 지난 표본에서 본 관계이고 통계적 입증이 아니다 · 한국은 1년 간격이 서로 겹치는 분기라 독립된 해는 2개 안팎, 미국은 한 해에 회사 십여 곳이다 · 뒤따른 변화는 같은 기간 표본 중앙 대비 P/B 변화이고 주가 수익률이 아니다 · 정의 ①은 '평소'를 만들 기간이 필요해 검증 기간이 더 짧다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is a relationship seen in the past sample, not statistical proof · for Korea the one-year windows are overlapping quarters, so there are only about two independent years, and the US has around a dozen companies a year · the subsequent change is the change in P/B against the sample median over the same period, not the share-price return · definition ① needs a period to build the 'usual' level, so its test period is shorter · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
검증Test検証Within definition ①: which part was followed by a lower P/B — the P/E part or the ROE part?
P/B 가 평소보다 높은 까닭이 배수(P/E)인 경우와 이익(ROE)인 경우를 갈라, 그 뒤 P/B 변화와의 순위상관을 봤다. 일본 1년: 배수 몫 -0.04 / 이익 몫 -0.01 · 일본 3년: 배수 몫 -0.11 / 이익 몫 -0.02 · 미국 1년: 배수 몫 0.01 / 이익 몫 -0.03.
Splitting cases where P/B is above its usual level because of the multiple (P/E) from those where it is because of earnings (ROE), the rank correlation with the subsequent change in P/B was examined. Japan, 1 year: multiple part -0.04 / earnings part -0.01 · Japan, 3 years: multiple part -0.11 / earnings part -0.02 · US, 1 year: multiple part 0.01 / earnings part -0.03.
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: 지난 표본에서 본 관계이고 통계적 입증이 아니다 · 한국은 1년 간격이 서로 겹치는 분기라 독립된 해는 2개 안팎, 미국은 한 해에 회사 십여 곳이다 · 뒤따른 변화는 같은 기간 표본 중앙 대비 P/B 변화이고 주가 수익률이 아니다 · 정의 ①은 '평소'를 만들 기간이 필요해 검증 기간이 더 짧다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: U.S. Securities and Exchange Commission (EDGAR).
Limitations: This is a relationship seen in the past sample, not statistical proof · for Korea the one-year windows are overlapping quarters, so there are only about two independent years, and the US has around a dozen companies a year · the subsequent change is the change in P/B against the sample median over the same period, not the share-price return · definition ① needs a period to build the 'usual' level, so its test period is shorter · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
05
회사별 — 시가총액이 큰 회사의 세 정의By company — the three definitions for the largest companies企業別 — 時価総額上位企業の三つの定義
한국Korea韓国Korea: the three definitions for the largest companies in the sample
회사
P/B
P/E
ROE
① P/B 평소 대비
배수 몫
이익 몫
② 동료 대비
③ 내재 수익률
요구 ROE
삼성전자
2.81
8.0
35.2%
+66
-70
+136
+5
2.9%
18.1%
SK하이닉스
4.20
6.8
61.2%
+43
-40
+83
+48
2.4%
27.0%
SK스퀘어
24.37
618.9
3.9%
n/a
n/a
n/a
+281
0.3%
157.0%
삼성전기
10.91
88.7
12.3%
+180
+125
+55
+177
0.6%
70.3%
LG에너지솔루션
4.43
적자
-12.8%
n/a
n/a
n/a
+134
1.4%
28.6%
현대차
0.69
10.6
6.5%
+15
+60
-45
-82
11.4%
4.5%
삼성바이오로직스
7.40
35.7
20.7%
+11
-36
+47
+129
1.0%
47.7%
KB금융
0.98
9.4
10.5%
+42
+33
+9
n/a
8.0%
6.3%
삼성물산
0.68
33.0
2.1%
-13
+43
-56
-63
8.8%
4.4%
두산에너빌리티
7.00
239.8
2.9%
+96
+28
+68
+180
1.0%
45.1%
한화에어로스페이스
4.65
37.2
12.5%
+6
+62
-56
+94
1.7%
30.0%
삼성생명
0.42
17.6
2.4%
-19
+47
-67
n/a
13.8%
2.7%
기준: 2026-09-30.
Company
P/B
P/E
ROE
① P/B vs own usual
Multiple part
Earnings part
② vs peers
③ Implied return
Required ROE
Samsung Electronics
2.81
8.0
35.2%
+66
-70
+136
+5
2.9%
18.1%
SK hynix
4.20
6.8
61.2%
+43
-40
+83
+48
2.4%
27.0%
SK Square
24.37
618.9
3.9%
n/a
n/a
n/a
+281
0.3%
157.0%
Samsung Electro-Mechanics
10.91
88.7
12.3%
+180
+125
+55
+177
0.6%
70.3%
LG Energy Solution
4.43
Loss
-12.8%
n/a
n/a
n/a
+134
1.4%
28.6%
Hyundai Motor
0.69
10.6
6.5%
+15
+60
-45
-82
11.4%
4.5%
Samsung Biologics
7.40
35.7
20.7%
+11
-36
+47
+129
1.0%
47.7%
KB Financial Group
0.98
9.4
10.5%
+42
+33
+9
n/a
8.0%
6.3%
Samsung C&T
0.68
33.0
2.1%
-13
+43
-56
-63
8.8%
4.4%
Doosan Enerbility
7.00
239.8
2.9%
+96
+28
+68
+180
1.0%
45.1%
Hanwha Aerospace
4.65
37.2
12.5%
+6
+62
-56
+94
1.7%
30.0%
Samsung Life Insurance
0.42
17.6
2.4%
-19
+47
-67
n/a
13.8%
2.7%
As of 2026-09-30.
企業
PBR
PER
ROE
① PBRの平常値比
倍率要因
利益要因
② 比較企業比
③ インプライド期待収益率
要求ROE
Samsung Electronics
2.81
8.0
35.2%
+66
-70
+136
+5
2.9%
18.1%
SK hynix
4.20
6.8
61.2%
+43
-40
+83
+48
2.4%
27.0%
SK Square
24.37
618.9
3.9%
n/a
n/a
n/a
+281
0.3%
157.0%
Samsung Electro-Mechanics
10.91
88.7
12.3%
+180
+125
+55
+177
0.6%
70.3%
LG Energy Solution
4.43
赤字
-12.8%
n/a
n/a
n/a
+134
1.4%
28.6%
Hyundai Motor
0.69
10.6
6.5%
+15
+60
-45
-82
11.4%
4.5%
Samsung Biologics
7.40
35.7
20.7%
+11
-36
+47
+129
1.0%
47.7%
KB Financial Group
0.98
9.4
10.5%
+42
+33
+9
n/a
8.0%
6.3%
Samsung C&T
0.68
33.0
2.1%
-13
+43
-56
-63
8.8%
4.4%
Doosan Enerbility
7.00
239.8
2.9%
+96
+28
+68
+180
1.0%
45.1%
Hanwha Aerospace
4.65
37.2
12.5%
+6
+62
-56
+94
1.7%
30.0%
Samsung Life Insurance
0.42
17.6
2.4%
-19
+47
-67
n/a
13.8%
2.7%
基準:2026-09-30。
한국 표본에서 시가총액이 큰 12사. ①·② 는 로그 차이 × 100(+69 = 2배), ③ 은 연 수익률. '요구 ROE' 는 이 시장의 평소 요구수익률(6.4%)로 지금 P/B 를 받치는 데 필요한 ROE 다.
The 12 largest companies by market capitalisation in the Korea sample. ① and ② are log differences × 100 (+69 = double); ③ is an annual return. 'Required ROE' is the ROE needed to support today's P/B at this market's usual required return (6.4%).
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
출처 : ECOS(한국은행, 시장금리(일별)), 2026.11.15
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
출처 : ECOS(한국은행, 시장금리(일별)), 2026.11.15
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
일본Japan日本Japan: the three definitions for the largest companies in the sample
회사
P/B
P/E
ROE
① P/B 평소 대비
배수 몫
이익 몫
② 동료 대비
③ 내재 수익률
요구 ROE
SoftBank Group Corp.
1.17
4.1
28.6%
-33
-52
+19
-133
6.9%
9.1%
MITSUI & CO., LTD.
1.93
20.5
9.4%
+78
+95
-17
+59
3.9%
15.0%
Recruit Holdings Co., Ltd.
5.77
18.7
30.8%
+7
-57
+63
+54
1.4%
44.9%
Panasonic Holdings Corporation
1.16
31.9
3.6%
+5
+101
-96
+51
5.9%
9.0%
MS&AD Insurance Group Holdings, Inc.
1.23
7.6
16.1%
+48
-32
+80
-14
7.0%
9.6%
Sompo Holdings, Inc.
1.04
8.6
12.1%
+11
-35
+46
-0
8.5%
8.1%
Daiichi Life Group, Inc.
1.21
11.9
10.1%
+62
+14
+48
+30
6.3%
9.4%
BRIDGESTONE CORPORATION
1.23
14.3
8.6%
-3
+23
-26
+23
5.9%
9.6%
ENEOS Holdings, Inc.
1.13
14.7
7.7%
+53
+70
-17
+25
6.2%
8.8%
INPEX CORPORATION
0.77
9.5
8.1%
+38
-21
+59
-25
9.5%
6.0%
NIPPON STEEL CORPORATION
0.54
175.4
0.3%
-17
+321
-338
-25
12.1%
4.2%
Shionogi & Co., Ltd.
1.75
14.4
12.2%
-25
-4
-21
+18
4.4%
13.7%
기준: 2026-03-31.
Company
P/B
P/E
ROE
① P/B vs own usual
Multiple part
Earnings part
② vs peers
③ Implied return
Required ROE
SoftBank Group Corp.
1.17
4.1
28.6%
-33
-52
+19
-133
6.9%
9.1%
MITSUI & CO., LTD.
1.93
20.5
9.4%
+78
+95
-17
+59
3.9%
15.0%
Recruit Holdings Co., Ltd.
5.77
18.7
30.8%
+7
-57
+63
+54
1.4%
44.9%
Panasonic Holdings Corporation
1.16
31.9
3.6%
+5
+101
-96
+51
5.9%
9.0%
MS&AD Insurance Group Holdings, Inc.
1.23
7.6
16.1%
+48
-32
+80
-14
7.0%
9.6%
Sompo Holdings, Inc.
1.04
8.6
12.1%
+11
-35
+46
-0
8.5%
8.1%
Daiichi Life Group, Inc.
1.21
11.9
10.1%
+62
+14
+48
+30
6.3%
9.4%
BRIDGESTONE CORPORATION
1.23
14.3
8.6%
-3
+23
-26
+23
5.9%
9.6%
ENEOS Holdings, Inc.
1.13
14.7
7.7%
+53
+70
-17
+25
6.2%
8.8%
INPEX CORPORATION
0.77
9.5
8.1%
+38
-21
+59
-25
9.5%
6.0%
NIPPON STEEL CORPORATION
0.54
175.4
0.3%
-17
+321
-338
-25
12.1%
4.2%
Shionogi & Co., Ltd.
1.75
14.4
12.2%
-25
-4
-21
+18
4.4%
13.7%
As of 2026-03-31.
企業
PBR
PER
ROE
① PBRの平常値比
倍率要因
利益要因
② 比較企業比
③ インプライド期待収益率
要求ROE
SoftBank Group Corp.
1.17
4.1
28.6%
-33
-52
+19
-133
6.9%
9.1%
MITSUI & CO., LTD.
1.93
20.5
9.4%
+78
+95
-17
+59
3.9%
15.0%
Recruit Holdings Co., Ltd.
5.77
18.7
30.8%
+7
-57
+63
+54
1.4%
44.9%
Panasonic Holdings Corporation
1.16
31.9
3.6%
+5
+101
-96
+51
5.9%
9.0%
MS&AD Insurance Group Holdings, Inc.
1.23
7.6
16.1%
+48
-32
+80
-14
7.0%
9.6%
Sompo Holdings, Inc.
1.04
8.6
12.1%
+11
-35
+46
-0
8.5%
8.1%
Daiichi Life Group, Inc.
1.21
11.9
10.1%
+62
+14
+48
+30
6.3%
9.4%
BRIDGESTONE CORPORATION
1.23
14.3
8.6%
-3
+23
-26
+23
5.9%
9.6%
ENEOS Holdings, Inc.
1.13
14.7
7.7%
+53
+70
-17
+25
6.2%
8.8%
INPEX CORPORATION
0.77
9.5
8.1%
+38
-21
+59
-25
9.5%
6.0%
NIPPON STEEL CORPORATION
0.54
175.4
0.3%
-17
+321
-338
-25
12.1%
4.2%
Shionogi & Co., Ltd.
1.75
14.4
12.2%
-25
-4
-21
+18
4.4%
13.7%
基準:2026-03-31。
일본 표본에서 시가총액이 큰 12사. ①·② 는 로그 차이 × 100(+69 = 2배), ③ 은 연 수익률. '요구 ROE' 는 이 시장의 평소 요구수익률(7.8%)로 지금 P/B 를 받치는 데 필요한 ROE 다.
The 12 largest companies by market capitalisation in the Japan sample. ① and ② are log differences × 100 (+69 = double); ③ is an annual return. 'Required ROE' is the ROE needed to support today's P/B at this market's usual required return (7.8%).
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
미국US米国US: the three definitions for the largest companies in the sample
회사
P/B
P/E
ROE
① P/B 평소 대비
배수 몫
이익 몫
② 동료 대비
③ 내재 수익률
요구 ROE
Microsoft Corp
9.21
30.2
34.4%
-4
-2
-2
+55
1.7%
42.2%
Amazon.com, Inc.
6.35
30.0
24.8%
-67
-107
+40
+62
2.3%
29.1%
Alphabet Inc.
5.24
16.4
34.8%
+16
-39
+54
+42
3.1%
24.0%
Meta Platforms, Inc.
8.20
22.4
40.6%
+45
-20
+64
+74
1.9%
37.6%
Walmart Inc.
4.35
18.4
24.5%
+72
+36
+36
-25
3.5%
19.9%
Oracle Corp
8.16
20.4
53.9%
+36
+30
+6
+36
5.2%
37.4%
S&P Global Inc.
4.82
40.1
11.8%
-183
+28
-210
+46
2.8%
22.1%
GE Vernova Inc.
16.22
124.6
12.9%
n/a
n/a
n/a
+136
0.9%
74.3%
NextEra Energy, Inc.
2.81
24.1
11.8%
-4
+1
-5
n/a
5.1%
12.9%
TJX Companies Inc
15.79
28.1
59.8%
+23
+7
+16
+54
1.1%
72.4%
Intercontinental Exchange, Inc.
3.67
34.8
10.9%
+38
+41
-3
-3
3.7%
16.8%
CME Group Inc.
3.56
26.6
13.4%
+48
+7
+41
-11
3.9%
16.3%
기준: 2026-05-31.
Company
P/B
P/E
ROE
① P/B vs own usual
Multiple part
Earnings part
② vs peers
③ Implied return
Required ROE
Microsoft Corp
9.21
30.2
34.4%
-4
-2
-2
+55
1.7%
42.2%
Amazon.com, Inc.
6.35
30.0
24.8%
-67
-107
+40
+62
2.3%
29.1%
Alphabet Inc.
5.24
16.4
34.8%
+16
-39
+54
+42
3.1%
24.0%
Meta Platforms, Inc.
8.20
22.4
40.6%
+45
-20
+64
+74
1.9%
37.6%
Walmart Inc.
4.35
18.4
24.5%
+72
+36
+36
-25
3.5%
19.9%
Oracle Corp
8.16
20.4
53.9%
+36
+30
+6
+36
5.2%
37.4%
S&P Global Inc.
4.82
40.1
11.8%
-183
+28
-210
+46
2.8%
22.1%
GE Vernova Inc.
16.22
124.6
12.9%
n/a
n/a
n/a
+136
0.9%
74.3%
NextEra Energy, Inc.
2.81
24.1
11.8%
-4
+1
-5
n/a
5.1%
12.9%
TJX Companies Inc
15.79
28.1
59.8%
+23
+7
+16
+54
1.1%
72.4%
Intercontinental Exchange, Inc.
3.67
34.8
10.9%
+38
+41
-3
-3
3.7%
16.8%
CME Group Inc.
3.56
26.6
13.4%
+48
+7
+41
-11
3.9%
16.3%
As of 2026-05-31.
企業
PBR
PER
ROE
① PBRの平常値比
倍率要因
利益要因
② 比較企業比
③ インプライド期待収益率
要求ROE
Microsoft Corp
9.21
30.2
34.4%
-4
-2
-2
+55
1.7%
42.2%
Amazon.com, Inc.
6.35
30.0
24.8%
-67
-107
+40
+62
2.3%
29.1%
Alphabet Inc.
5.24
16.4
34.8%
+16
-39
+54
+42
3.1%
24.0%
Meta Platforms, Inc.
8.20
22.4
40.6%
+45
-20
+64
+74
1.9%
37.6%
Walmart Inc.
4.35
18.4
24.5%
+72
+36
+36
-25
3.5%
19.9%
Oracle Corp
8.16
20.4
53.9%
+36
+30
+6
+36
5.2%
37.4%
S&P Global Inc.
4.82
40.1
11.8%
-183
+28
-210
+46
2.8%
22.1%
GE Vernova Inc.
16.22
124.6
12.9%
n/a
n/a
n/a
+136
0.9%
74.3%
NextEra Energy, Inc.
2.81
24.1
11.8%
-4
+1
-5
n/a
5.1%
12.9%
TJX Companies Inc
15.79
28.1
59.8%
+23
+7
+16
+54
1.1%
72.4%
Intercontinental Exchange, Inc.
3.67
34.8
10.9%
+38
+41
-3
-3
3.7%
16.8%
CME Group Inc.
3.56
26.6
13.4%
+48
+7
+41
-11
3.9%
16.3%
基準:2026-05-31。
미국 표본에서 시가총액이 큰 12사. ①·② 는 로그 차이 × 100(+69 = 2배), ③ 은 연 수익률. '요구 ROE' 는 이 시장의 평소 요구수익률(4.6%)로 지금 P/B 를 받치는 데 필요한 ROE 다.
The 12 largest companies by market capitalisation in the US sample. ① and ② are log differences × 100 (+69 = double); ③ is an annual return. 'Required ROE' is the ROE needed to support today's P/B at this market's usual required return (4.6%).
Source: U.S. Securities and Exchange Commission (EDGAR).
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: 이익을 모두 주주에게 돌려주고 장부가 늘지 않는다고 놓은 우리 추정값이다 — ROE 가 높고 재투자가 많은 회사는 내재 수익률이 낮게 나온다 · ROE 가 시장 중앙으로 수렴하는 속도 가정에 따라 수준이 달라진다(순위는 거의 그대로) · 국채 금리는 결산일 무렵의 10년물 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: U.S. Securities and Exchange Commission (EDGAR).
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Limitations: This is our own estimate, assuming all earnings are returned to shareholders and book value does not grow — companies with high ROE and heavy reinvestment come out with a low implied return · the level depends on the assumed speed at which ROE converges to the market median (the ranking barely changes) · the government bond yield is the 10-year yield around the fiscal year-end · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: U.S. Securities and Exchange Commission (EDGAR).
Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
한국Korea韓国Korea: does inventory add to the peer comparison?
지표
P/B 와의 관계
t
ROE 1%p
+3.8%
4.7
FCF/자본 1%p
-1.1%
-2.2
자기자본비율 10%p
-0.5%
-0.1
재고/매출 10%p
+18.3%
3.2
재고/매출 1년 변화 10%p
-33.9%
-2.5
분기 효과를 빼고 회사 단위로 묶어 계산한 값.
Measure
Relation to P/B
t
ROE 1pp
+3.8%
4.7
FCF-to-equity 1pp
-1.1%
-2.2
Equity ratio 10pp
-0.5%
-0.1
Inventory/revenue 10pp
+18.3%
3.2
One-year change in inventory/revenue 10pp
-33.9%
-2.5
Calculated with quarter effects removed and clustered by company.
指標
PBRとの関係
t
ROE 1%pt
+3.8%
4.7
FCF/自己資本 1%pt
-1.1%
-2.2
自己資本比率 10%pt
-0.5%
-0.1
在庫/売上高 10%pt
+18.3%
3.2
在庫/売上高の1年変化 10%pt
-33.9%
-2.5
四半期効果を除き、企業単位でクラスタリングして計算した値。
재고 자료가 있는 한국 비금융 173사(8개 분기)로, 정의 ②의 세 지표에 재고/매출과 그 1년 변화를 더했다. 재고/매출이 1년 사이 10%p 늘어난 회사의 P/B 는 다른 조건이 같을 때 약 -34% 였다(t -2.5).
Using 173 Korean non-financial companies with inventory data (8 quarters), inventory to revenue and its one-year change were added to the three measures of definition ②. For a company whose inventory-to-revenue rose by 10pp over a year, P/B was about -34% with other things equal (t -2.5).
⚠ 규율: 같은 시점의 관계이고 인과가 아니다. 일본·미국은 같은 자료가 없어 재지 못했다.
⚠ Discipline: This is a same-period relationship, not causation. Japan and the US could not be measured because the same data are not available.
⚠ 規律:同時点の関係であり因果ではない。日本・米国は同じデータがないため測れなかった。
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: 회사별 잔차는 같은 기간 같은 시장 안의 상대값이라 평균이 0 이다 — 시장 전체의 수준은 '같은 회사에 매기는 P/B' 로만 본다 · 금융업은 현금흐름·자기자본비율 항을 쓰지 않았다 · 미국은 회사 수가 적어 여러 해를 모아 추정했다 · 일본의 FCF 는 영업현금흐름 + 투자현금흐름(유가증권 매매·인수 포함)이다 · 한국은 분기말 시가총액 자료가 2023년부터라 견줄 '평소'가 2년 안팎으로 짧다 · 일본은 유가증권보고서 요약표의 주가수익률로 기말 주가를 되짚어 적자 해가 빠지고, 업종 비례 무작위 표본이다 · 미국은 10-K 표지에 적힌 비계열 주주 보유 시가총액(연 1회, 대주주·임원 지분 제외)이라 배수가 실제보다 낮고, 회사 수가 적으며 무작위 표본이 아니다 · 세 시장의 기준 시점(한국 6월 말 · 일본 3월 결산 중심 · 미국 회사별 회계연도)과 표본 구성이 달라 수준을 그대로 맞대기 어렵다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Limitations: Company residuals are relative values within the same market and period, so they average zero — the level of the market as a whole is seen only through 'the P/B given to the same company' · for financials, the cash-flow and equity-ratio terms are not used · the US is estimated with several years pooled because it has few companies · Japan's FCF is operating cash flow + investing cash flow (including securities trading and acquisitions) · Korea's quarter-end market capitalisation data start in 2023, so the 'usual' level it is compared with is short, around two years · Japan's year-end share price is backed out from the P/E in the summary table of the annual securities report, so loss-making years drop out, and the sample is random and proportional by industry · US figures use the market value held by non-affiliates stated on the 10-K cover (once a year, excluding major shareholders' and officers' stakes), so multiples are lower than actual, there are few companies and the sample is not random · the three markets differ in reference date (Korea end-September · Japan mostly March year-ends · US each company's fiscal year) and in sample make-up, so their levels are hard to compare directly.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
Source: DART, Financial Supervisory Service.
Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE
Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage
∞
천장 — 이 페이지가 말할 수 없는 것Ceilings — what this page cannot say限界 — このページが言えないこと
정의마다 답이 다르다. ①은 그 회사의 지난 몇 해가 기준이라 그 기간이 비쌌다면 지금도 '평소'로 나온다. ②는 시장 안의 상대값이라 시장 전체가 비싼지는 말하지 못한다. ③은 가정에 따라 수준이 움직인다.
한국의 '평소'는 2년 안팎이다. 분기말 시가총액과 직전 4분기 이익이 함께 있는 기간이 2023년 말부터다.
미국은 비계열 주주 보유 시가총액이다. 연 1회, 대주주·임원 지분이 빠진 값이고 회사 수가 적다.
일본은 적자 해가 빠진다. 주가를 주가수익률로 되짚기 때문이다.
③은 재투자 성장을 넣지 않았다. ROE 가 높고 유보가 큰 회사는 내재 수익률이 낮게 나온다.
검증은 P/B 변화다. 주가 수익률이 아니고, 기간이 짧아 통계적 입증이 아니다.
Each definition gives a different answer. ① is based on the company's last few years, so if that period was expensive, today still comes out as 'usual'. ② is relative within the market, so it cannot say whether the market as a whole is expensive. ③ moves in level with its assumptions.
Korea's 'usual' covers about two years. The period with both quarter-end market capitalisation and trailing four-quarter earnings starts at the end of 2023.
The US uses the market value held by non-affiliates. It is once a year, excludes major shareholders' and officers' stakes, and the companies are few.
Japan drops loss-making years. This is because the share price is backed out from the P/E.
③ leaves out growth from reinvestment. Companies with high ROE and large retained earnings come out with a low implied return.
The test is on the change in P/B. It is not the share-price return, and the period is short, so it is not statistical proof.
Source: DART, Financial Supervisory Service. Source: Korea Exchange (KRX). 본 차트는 “한국거래소 통계정보”를 사용한 결과임. 出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0) EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の各社提出書類(有価証券報告書)をもとにAdrenalin Baby作成(編集・加工) Source: U.S. Securities and Exchange Commission (EDGAR). 출처 : ECOS(한국은행, 시장금리(일별)), 2026.11.15 出典:「国債金利情報」(財務省)(https://www.mof.go.jp/jgbs/reference/interest_rate/index.htm)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)(2026年11月15日に利用) 「国債金利情報」(財務省)(https://www.mof.go.jp/jgbs/reference/interest_rate/index.htm)をもとにAdrenalin Baby作成(編集・加工) Source: Board of Governors of the Federal Reserve System (US) via FRED®, Federal Reserve Bank of St. Louis.